Back
Avadel Pharmaceuticals PLC 10K Form
Sell
34
AVDL
Avadel Pharmaceuticals PLC
Last Price:
11.07
Seasonality Move:
21.3%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-08 | 10Q | AVDL/Avadel Pharmaceuticals PLC Quarterly |
| 2023-08-09 | 10Q | AVDL/Avadel Pharmaceuticals PLC Quarterly |
| 2023-05-04 | 10Q | AVDL/Avadel Pharmaceuticals PLC Quarterly |
| 2022-11-09 | 10Q | AVDL/Avadel Pharmaceuticals PLC Quarterly |
| 2022-08-09 | 10Q | AVDL/Avadel Pharmaceuticals PLC Quarterly |
| 2022-05-09 | 10Q | AVDL/Avadel Pharmaceuticals PLC Quarterly |
Receive AVDL News And Ratings
See the #1 stock for the next 7 days that we like better than AVDL
AVDL Financial Statistics
Sales & Book Value
| Annual Sales: | $27.96M |
|---|---|
| Cash Flow: | $-6.89M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.78 |
| Price / Book: | 14.39 |
Profitability
| EPS (TTM): | -0.76000 |
|---|---|
| Net Income (TTM): | $-72.58M |
| Gross Margin: | $27.12M |
| Return on Equity: | -86.15% |
| Return on Assets: | -42.62% |
Avadel Pharmaceuticals PLC Earnings Forecast
Key Avadel Pharmaceuticals PLC Financial Ratios
- The Gross Profit Margin over the past 28 years for AVDL is 96.97%.
- The Selling, General & Administrative Expenses for AVDL have been equal to 542.52% of Gross Profit Margin.
- The Research & Development expenses have been 47.42% of Revenue.
- The Interest Expense is -6.17% of Operating Income.
- The Net Earning history of AVDL is -573.17% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 15 years.
Avadel Pharmaceuticals PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AVDL |
| CUSIP: | 05337M |
| Website: | avadel.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.97 |
| Quick Ratio: | 2.41 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 21.04 |
AVDL Technical Analysis vs Fundamental Analysis
Sell
34
Avadel Pharmaceuticals PLC (AVDL)
is a Sell
Is Avadel Pharmaceuticals PLC a Buy or a Sell?
-
Avadel Pharmaceuticals PLC stock is rated a Sell
The current Avadel Pharmaceuticals PLC [AVDL] share price is $11.15. The Score for AVDL is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.